The binding characteristics of a cyclic nonapeptide, c(CGRRAGGSC), in LNCaP human prostate cancer cells

Oncology Letters

Volumn 4, Issue 3, 2012, Pages 443-449

  Gu, Chen ^a   Liu, Lu ^b   He, Yujie ^c   Jiang, Jianwei ^a   Yang, Zexuan ^b   Wu, Qinghua ^a,b  

^a NANTONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^c Tumour Therapy Department with Western Medicine and Traditional Chinese Medicine   (China)

Author keywords

Fluorescent dyes; Interleukin 11 analog; LNCaP cells; Prostate cancer

Indexed keywords

CYCLIC CYSTEINYLGLYCYLARGINYLARGINYLALANYLGLYCYLGLYCYLSERYLCYSTEINE; FLUORESCENT DYE; INTERLEUKIN 11; INTERLEUKIN 11 RECEPTOR; NONAPEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; BINDING ASSAY; BONE METASTASIS; CANCER GROWTH; CELL MEMBRANE; CELL STRAIN LNCAP; CELLULAR DISTRIBUTION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG LABELING; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; DRUG UPTAKE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IC 50; ISOTOPE LABELING; MOLECULAR PROBE; PROSTATE CANCER;

EID: 84863880214     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.769     Document Type: Article

References (19)

1. Du X and Williams DA: Interleukin-11: review of molecular, cell biology, and clinical use. Blood 89: 3897-3908, 1997.
2. Schleinkofer K, Dingley A, Tacken I, Federwisch M and Müller-Newen G: Identification of the domain in the human interleukin-11 receptor that mediates ligand binding. J Mol Biol 306: 263-274, 2001.
3. Dahmen H, Horsten U, Küster A, et al: Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions. Biochem J 331: 695-702, 1998.
4. Kurth I, Horsten U, Pflanz S, et al: Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes. J Immunol 162: 1480-1487, 1999.
5. Zurita AJ, Troncoso P, Cardó-Vila M, Logothetis CJ, Pasqualini R and Arap W: Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancer. Cancer Res 64: 435-439, 2004.
6. Nakayama T, Yoshizaki A, Izumida S, et al: Expression of interleukin-11(IL-11) and IL-11 receptor alpha in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells. Int J Oncol 30: 825-833, 2007.
7. Yoshizaki A, Nakayama T, Yamazumi K, Yakata Y, Taba M and Sekine I: Expression of interleukin (IL)-11 and IL-11 receptor in human colorectal adenocarcinoma: IL-11 up-regulation of the invasive and proliferative activity of human colorectal carcinoma cells. Int J Oncol 29: 869-876, 2006.
8. Campbell CL, Jiang Z, Savarese DM and Savarese TM: Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma. Am J Pathol 158: 25-32, 2001.
9. Wang W, Ke S, Kwon S, et al: A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain. Bioconjug Chem 18: 397-402, 2007.
10. Cook RJ and Major P: Multistate analysis of skelet al events in patients with bone metastases. Clin Cancer Res 12: 6264s-6269s, 2006.
11. Morgentaler A: Testosterone and prostate cancer: an historical perspective on a modern myth. Eur Urol 50: 935-939, 2006.
12. Ernst M, Najdovska M, Grail D, et al: STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 118: 1727-1738, 2008.
13. Nandurkar HH, Hilton DJ, Nathan P, Willson T, Nicola N and Begley CG: The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor. Oncogene 12: 585-593, 1996.
14. Morgan H, Tumber A and Hill PA: Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor. Int J Cancer 109: 653-660, 2004.
15. Kang Y, He W, Tulley S, et al: Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. PNAS 102: 13909-13914, 2005.
16. Javelaud D, Mohammad KS, McKenna CR, et al: Stable overexpression of Smad7 in human melanoma cells impairs bone metastasis. Cancer Res 67: 2317-2324, 2007.
17. Shah K and Weissleder R: Molecular optical imaging: applications leading to the development of present day therapeutics. NeuroRx 2: 215-225, 2005.
18. Li C, Wang W, Wu Q, et al: Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe. Nucl Med Biol 33: 349-358, 2006.
19. Steinbrink J, Liebert A, Wabnitz H, et al: Towards noninvasive molecular fluorescence imaging of the human brain. Neurodegener Dis 5: 296-303, 2008.